TAP Block or Wound Infiltration for Laparoscopic Pediatric Appendectomy: a Pilot Study

March 1, 2020 updated by: Andrea Luigi Ambrosoli, Ospedale di Circolo - Fondazione Macchi

TAP Block or Wound Infiltration for Laparoscopic Pediatric Appendectomy: Prospective Randomized Study

Effectiveness of the TAP block compared to wound infiltration in controlling pain after laparoscopic appendectomy in children

Study Overview

Detailed Description

Laparoscopic appendectomy is one of the main emergency surgical procedures performed in children.

The available local anesthesia techniques include wound infiltration or "wall" blocks such as the TAP (transversus abdominis plane) block.

The greater evidence on the adult population suggests that both techniques are valid for pain control in the immediate postoperative period, although wall blocks can guarantee a more prolonged analgesic effect over time.

The evidence on the pediatric population, on the other hand, is less strong and sometimes conflicting: therefore, the objective of our study is to verify the efficacy of TAP block compared to wound infiltration in the control of postoperative pain after appendectomy in pediatric patients.

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • VA
      • Varese, VA, Italy, 21100
        • Department of Day Surgery Ospedale di Circolo Varese

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged between 3 and 16 years, candidates for laparoscopic appendectomy for suspected acute appendicitis.
  • ASA physical status Class I and II
  • Informed consent signed by parents / legal guardians

Exclusion Criteria:

  • severe obesity (BMI> 95th percentile for age and weight)
  • perforated appendicitis
  • paralytic ileum
  • non-stabilized neuropathies
  • allergy to local anesthetics or analgesics used in the study protocol.
  • patients on chronic opiate treatment
  • need for perioperative hospitalization in intensive care with sedation and / or mechanical ventilation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAP block
Bilateral ultrasound-guided single-shot TAP block with 0,15% levobupivacaine 0,75 mg/kg per side.
At the end of surgery patients will receive bilateral ultrasound-guided single-shot TAP block: 0,15% levobupivacaine 0,75 mg/kg per side will be injected between internal oblique and transveralis fascia

General anesthesia will be induced with fentanyl 1,5 mcg/kg, propofol 2 mg/kg, rocuronium 0,6 mg/kg; after intubation anesthesia will be mantained with sevoflurane (MAC 1).

30 minutes after induction will be administered paracetamol 15 mg/kg iv.

During first 48 hours after surgery all patients wil receive paracetamol 15 mg/kg iv every 8 hours and ibuprofen 10 mg/kg orally (or through gastric tube) every 12 hours after surgery.

In case of severe pain tramadol 0,5 mg/kg will be administered iv every 8 hours.

Active Comparator: LIA - local wound infiltration
Wound infiltration with 0,5% levobupivacaine 1.5 mg/kg

General anesthesia will be induced with fentanyl 1,5 mcg/kg, propofol 2 mg/kg, rocuronium 0,6 mg/kg; after intubation anesthesia will be mantained with sevoflurane (MAC 1).

30 minutes after induction will be administered paracetamol 15 mg/kg iv.

During first 48 hours after surgery all patients wil receive paracetamol 15 mg/kg iv every 8 hours and ibuprofen 10 mg/kg orally (or through gastric tube) every 12 hours after surgery.

In case of severe pain tramadol 0,5 mg/kg will be administered iv every 8 hours.

At the end of surgery 0,5% levobupivacaine 1.5 mg/kg, equally distributed between ports, injected in the skin and subcutaneous tissue during wound closure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain at 2 hours
Time Frame: 2 hours
Difference in pain severity (assessed by Wong Baker for under 8 year and visual analog scale dor older than 8) of TAP block goup compared to wound infiltration group 2 hours after the end of the surgery.
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain at 4-12-24 hours
Time Frame: from 4 to 24 postoperative hours
Difference in pain severity (assessed by Wong Baker for under 8 year and visual analog scale dor older than 8) of TAP block goup compared to wound infiltration group 4 hours, 12 hours and 24 hours from the end of the surgery.
from 4 to 24 postoperative hours
Total opioid consumption
Time Frame: from 2 to 24 postoperative hours
Differences in tramadol rescue use (expressed in mg/kg) in the TAP group compared to the LIA group
from 2 to 24 postoperative hours
time to first opioid analgesic rescue
Time Frame: from 2 to 24 postoperative hours
Differences in the elapsed time before first request for tramadol rescue in the TAP group compared to the LIA group
from 2 to 24 postoperative hours
Side effects
Time Frame: from 2 to 24 postoperative hours
Differences in the incidence of side effects depending on the anesthetic technique adopted
from 2 to 24 postoperative hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 30, 2020

Primary Completion (Anticipated)

April 30, 2020

Study Completion (Anticipated)

May 30, 2020

Study Registration Dates

First Submitted

November 9, 2019

First Submitted That Met QC Criteria

March 1, 2020

First Posted (Actual)

March 4, 2020

Study Record Updates

Last Update Posted (Actual)

March 4, 2020

Last Update Submitted That Met QC Criteria

March 1, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laparoscopy

Clinical Trials on TAP Block

3
Subscribe